Lauren Adams

732 total citations
21 papers, 460 citations indexed

About

Lauren Adams is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Lauren Adams has authored 21 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Organic Chemistry and 10 papers in Molecular Biology. Recurrent topics in Lauren Adams's work include Synthesis and pharmacology of benzodiazepine derivatives (10 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer therapeutics and mechanisms (7 papers). Lauren Adams is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (10 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer therapeutics and mechanisms (7 papers). Lauren Adams collaborates with scholars based in United Kingdom, United States and Australia. Lauren Adams's co-authors include Philip W. Howard, John A. Hartley, David G. Williams, Simon Corbett, Arnaud Tiberghien, Luke A. Masterson, Neki V. Patel, Francesca Zammarchi, Simon Chivers and Patrick H. van Berkel and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Lauren Adams

21 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lauren Adams United Kingdom	9	332	179	123	102	82	21	460
Anja Schmid Switzerland	10	116 0.3×	72 0.4×	150 1.2×	59 0.6×	15 0.2×	15	318
Anja Löffler Germany	5	393 1.2×	342 1.9×	325 2.6×	27 0.3×	81 1.0×	7	745
Joanna Stachura Poland	11	99 0.3×	62 0.3×	155 1.3×	13 0.1×	70 0.9×	21	417
Jeffrey I. Bennett United States	9	117 0.4×	285 1.6×	291 2.4×	27 0.3×	49 0.6×	13	572
Geoffrey Kuesters United States	10	126 0.4×	67 0.4×	186 1.5×	7 0.1×	51 0.6×	18	400
Tatiana Besse‐Hammer Belgium	12	169 0.5×	42 0.2×	111 0.9×	18 0.2×	25 0.3×	35	353
Eduardo E. Mundo United States	10	269 0.8×	335 1.9×	186 1.5×	22 0.2×	7 0.1×	12	483
Sabrina Amar United States	7	78 0.2×	27 0.2×	110 0.9×	14 0.1×	14 0.2×	10	306
Sasha Belenkov United States	9	106 0.3×	42 0.2×	178 1.4×	11 0.1×	19 0.2×	16	438
Jason H. Williams United States	12	44 0.1×	32 0.2×	319 2.6×	53 0.5×	26 0.3×	27	532

Countries citing papers authored by Lauren Adams

Since Specialization

Citations

This map shows the geographic impact of Lauren Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Adams more than expected).

Fields of papers citing papers by Lauren Adams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Adams. The network helps show where Lauren Adams may publish in the future.

Co-authorship network of co-authors of Lauren Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Adams. A scholar is included among the top collaborators of Lauren Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Adams. Lauren Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tiberghien, Arnaud, Balakumar Vijayakrishnan, John P. Bingham, et al.. (2022). Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity. Molecular Cancer Therapeutics. 22(2). 254–263. 3 indexed citations

Gregson, Stephen J., Neki V. Patel, Balakumar Vijayakrishnan, et al.. (2022). Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody–Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer. Molecular Cancer Therapeutics. 21(9). 1439–1448. 4 indexed citations

Adams, Lauren, et al.. (2022). Iron-Based Tandem Catalysis: From Petroleum toward Pharmaceutical Laboratories for Organic Undergraduate Students─Product Identification by TLC and ¹H NMR. Journal of Chemical Education. 99(9). 3259–3264. 1 indexed citations

Amant, André H. St., Feng‐Ying Huang, Shenlan Mao, et al.. (2019). A Reactive Antibody Platform for One-Step Production of Antibody–Drug Conjugates through a Diels–Alder Reaction with Maleimide. Bioconjugate Chemistry. 30(9). 2340–2348. 21 indexed citations

Gregson, Stephen J., Allison Barrett, Neki V. Patel, et al.. (2019). Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers. European Journal of Medicinal Chemistry. 179. 591–607. 16 indexed citations

Sonzini, Silvia, Lauren Adams, Luke A. Masterson, et al.. (2019). Improved Physical Stability of an Antibody–Drug Conjugate Using Host–Guest Chemistry. Bioconjugate Chemistry. 31(1). 123–129. 8 indexed citations

Adams, Lauren, Luke A. Masterson, Neki V. Patel, et al.. (2019). Potentiation of PBD Dimers by Lipophilicity Manipulation. Current Topics in Medicinal Chemistry. 19(9). 741–752. 6 indexed citations

Hartley, John A., Michael Flynn, John P. Bingham, et al.. (2018). Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine. Scientific Reports. 8(1). 10479–10479. 85 indexed citations

Zammarchi, Francesca, Simon Corbett, Lauren Adams, et al.. (2018). ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies. Blood. 131(10). 1094–1105. 118 indexed citations

10.

Liebman, Tracey N., et al.. (2017). Palmoplantar exacerbation of psoriasis after nivolumab for lung cancer. The Journal of Community and Supportive Oncology. 15(2). 106–108. 3 indexed citations

11.

Tiberghien, Arnaud, Stephen J. Gregson, Luke A. Masterson, et al.. (2017). An optimised synthesis of SG3376, a non-cleavable antibody-drug conjugate pyrrolobenzodiazepine drug-linker. Tetrahedron Letters. 58(46). 4363–4366. 6 indexed citations

12.

Tiberghien, Arnaud, Neki V. Patel, François D’Hooge, et al.. (2017). Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycin. Bioorganic & Medicinal Chemistry Letters. 27(5). 1154–1158. 15 indexed citations

13.

Zammarchi, Francesca, Simon Chivers, Karin Havenith, et al.. (2017). Abstract 3111A: ADCT-401/MEDI3726, a novel pyrrolobenzodiazepine (PBD)-based antibody-drug conjugate (ADC) targeting PSMA-expressing prostate cancers. Cancer Research. 77(13_Supplement). 3111A–3111A. 1 indexed citations

14.

Zammarchi, Francesca, Simon Chivers, David G. Williams, et al.. (2016). ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody–drug conjugate (ADC) targeting low HER2-expressing solid cancers. European Journal of Cancer. 69. S28–S28. 14 indexed citations

15.

Starmer, Heather M., et al.. (2016). The Impact of Dysphonic Voices on Healthy Listeners: Listener Reaction Times, Speech Intelligibility, and Listener Comprehension. American Journal of Speech-Language Pathology. 25(4). 561–575. 30 indexed citations

16.

Tiberghien, Arnaud, Luke A. Masterson, Neki V. Patel, et al.. (2016). Design and Synthesis of Tesirine, a Clinical Antibody–Drug Conjugate Pyrrolobenzodiazepine Dimer Payload. ACS Medicinal Chemistry Letters. 7(11). 983–987. 100 indexed citations

17.

Zammarchi, Francesca, David G. Williams, Lauren Adams, et al.. (2015). Pre-Clinical Development of Adct-402, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate (ADC) Targeting CD19-Expressing B-Cell Malignancies. Blood. 126(23). 1564–1564. 8 indexed citations

18.

Flynn, Michael, Francesca Zammarchi, Arnaud Tiberghien, et al.. (2014). Pre-Clinical Activity of Adct-301, a Novel Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. Blood. 124(21). 4491–4491. 7 indexed citations

19.

Hartley, John A., Luke A. Masterson, Stephen J. Gregson, et al.. (2013). Abstract 2856: Pyrrolobenzodiazepine (PBD) dimers - potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors.. Cancer Research. 73(8_Supplement). 2856–2856. 1 indexed citations

20.

Defauw, Jean, Lawrence M. Ballas, William P. Janzen, et al.. (1993). ChemInform Abstract: Novel Non‐Cross Resistant Diaminoanthraquinones as Potential Chemotherapeutic Agents.. ChemInform. 24(21). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact